nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextropropoxyphene—CYP3A7—Dexamethasone—ankylosing spondylitis	0.104	0.147	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.104	0.147	CbGbCtD
Dextropropoxyphene—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0805	0.114	CbGbCtD
Dextropropoxyphene—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0751	0.106	CbGbCtD
Dextropropoxyphene—CYP3A4—Triamcinolone—ankylosing spondylitis	0.061	0.0861	CbGbCtD
Dextropropoxyphene—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0524	0.0739	CbGbCtD
Dextropropoxyphene—CYP3A4—Betamethasone—ankylosing spondylitis	0.0523	0.0739	CbGbCtD
Dextropropoxyphene—CYP3A4—Prednisolone—ankylosing spondylitis	0.0517	0.0729	CbGbCtD
Dextropropoxyphene—CYP3A4—Prednisone—ankylosing spondylitis	0.0488	0.0689	CbGbCtD
Dextropropoxyphene—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0479	0.0676	CbGbCtD
Dextropropoxyphene—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0305	0.043	CbGbCtD
Dextropropoxyphene—Abnormal behaviour—Methylprednisolone—ankylosing spondylitis	0.0067	0.023	CcSEcCtD
Dextropropoxyphene—Metabolic acidosis—Methylprednisolone—ankylosing spondylitis	0.00632	0.0216	CcSEcCtD
Dextropropoxyphene—Drug withdrawal syndrome—Methylprednisolone—ankylosing spondylitis	0.00509	0.0174	CcSEcCtD
Dextropropoxyphene—Pancreatitis acute—Betamethasone—ankylosing spondylitis	0.00492	0.0169	CcSEcCtD
Dextropropoxyphene—Pancreatitis acute—Dexamethasone—ankylosing spondylitis	0.00492	0.0169	CcSEcCtD
Dextropropoxyphene—Drug withdrawal syndrome—Betamethasone—ankylosing spondylitis	0.00463	0.0159	CcSEcCtD
Dextropropoxyphene—Drug withdrawal syndrome—Dexamethasone—ankylosing spondylitis	0.00463	0.0159	CcSEcCtD
Dextropropoxyphene—Pancreatitis acute—Prednisone—ankylosing spondylitis	0.00428	0.0147	CcSEcCtD
Dextropropoxyphene—Drug withdrawal syndrome—Prednisone—ankylosing spondylitis	0.00403	0.0138	CcSEcCtD
Dextropropoxyphene—Myopathy—Prednisolone—ankylosing spondylitis	0.00388	0.0133	CcSEcCtD
Dextropropoxyphene—Hepatomegaly—Prednisolone—ankylosing spondylitis	0.00384	0.0132	CcSEcCtD
Dextropropoxyphene—Myopathy—Triamcinolone—ankylosing spondylitis	0.00357	0.0122	CcSEcCtD
Dextropropoxyphene—Myopathy—Methylprednisolone—ankylosing spondylitis	0.00356	0.0122	CcSEcCtD
Dextropropoxyphene—Hepatomegaly—Triamcinolone—ankylosing spondylitis	0.00353	0.0121	CcSEcCtD
Dextropropoxyphene—Hepatomegaly—Methylprednisolone—ankylosing spondylitis	0.00353	0.0121	CcSEcCtD
Dextropropoxyphene—Myopathy—Dexamethasone—ankylosing spondylitis	0.00324	0.0111	CcSEcCtD
Dextropropoxyphene—Myopathy—Betamethasone—ankylosing spondylitis	0.00324	0.0111	CcSEcCtD
Dextropropoxyphene—Hepatomegaly—Dexamethasone—ankylosing spondylitis	0.00321	0.011	CcSEcCtD
Dextropropoxyphene—Hepatomegaly—Betamethasone—ankylosing spondylitis	0.00321	0.011	CcSEcCtD
Dextropropoxyphene—Myopathy—Prednisone—ankylosing spondylitis	0.00282	0.00966	CcSEcCtD
Dextropropoxyphene—Hepatomegaly—Prednisone—ankylosing spondylitis	0.00279	0.00957	CcSEcCtD
Dextropropoxyphene—Euphoric mood—Prednisolone—ankylosing spondylitis	0.00234	0.00801	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Prednisolone—ankylosing spondylitis	0.00218	0.00746	CcSEcCtD
Dextropropoxyphene—Euphoric mood—Triamcinolone—ankylosing spondylitis	0.00215	0.00737	CcSEcCtD
Dextropropoxyphene—Euphoric mood—Methylprednisolone—ankylosing spondylitis	0.00214	0.00735	CcSEcCtD
Dextropropoxyphene—Visual disturbance—Prednisolone—ankylosing spondylitis	0.00208	0.00714	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Triamcinolone—ankylosing spondylitis	0.002	0.00686	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Methylprednisolone—ankylosing spondylitis	0.002	0.00685	CcSEcCtD
Dextropropoxyphene—Euphoric mood—Dexamethasone—ankylosing spondylitis	0.00195	0.00669	CcSEcCtD
Dextropropoxyphene—Euphoric mood—Betamethasone—ankylosing spondylitis	0.00195	0.00669	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Prednisolone—ankylosing spondylitis	0.00188	0.00644	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Dexamethasone—ankylosing spondylitis	0.00182	0.00623	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Betamethasone—ankylosing spondylitis	0.00182	0.00623	CcSEcCtD
Dextropropoxyphene—Psychotic disorder—Methylprednisolone—ankylosing spondylitis	0.00177	0.00607	CcSEcCtD
Dextropropoxyphene—Visual disturbance—Dexamethasone—ankylosing spondylitis	0.00174	0.00596	CcSEcCtD
Dextropropoxyphene—Visual disturbance—Betamethasone—ankylosing spondylitis	0.00174	0.00596	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Triamcinolone—ankylosing spondylitis	0.00173	0.00592	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Methylprednisolone—ankylosing spondylitis	0.00172	0.00591	CcSEcCtD
Dextropropoxyphene—Euphoric mood—Prednisone—ankylosing spondylitis	0.0017	0.00582	CcSEcCtD
Dextropropoxyphene—Psychotic disorder—Dexamethasone—ankylosing spondylitis	0.00161	0.00552	CcSEcCtD
Dextropropoxyphene—Psychotic disorder—Betamethasone—ankylosing spondylitis	0.00161	0.00552	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Prednisone—ankylosing spondylitis	0.00158	0.00542	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Dexamethasone—ankylosing spondylitis	0.00157	0.00537	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Betamethasone—ankylosing spondylitis	0.00157	0.00537	CcSEcCtD
Dextropropoxyphene—Coma—Methotrexate—ankylosing spondylitis	0.00151	0.00517	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Prednisolone—ankylosing spondylitis	0.0015	0.00514	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Prednisolone—ankylosing spondylitis	0.00149	0.00511	CcSEcCtD
Dextropropoxyphene—Gastrointestinal haemorrhage—Prednisone—ankylosing spondylitis	0.00144	0.00492	CcSEcCtD
Dextropropoxyphene—Psychotic disorder—Prednisone—ankylosing spondylitis	0.0014	0.0048	CcSEcCtD
Dextropropoxyphene—Bradycardia—Prednisolone—ankylosing spondylitis	0.00139	0.00477	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Triamcinolone—ankylosing spondylitis	0.00138	0.00473	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Methylprednisolone—ankylosing spondylitis	0.00138	0.00472	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Triamcinolone—ankylosing spondylitis	0.00137	0.0047	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Methylprednisolone—ankylosing spondylitis	0.00137	0.00469	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Prednisone—ankylosing spondylitis	0.00136	0.00468	CcSEcCtD
Dextropropoxyphene—Visual impairment—Prednisolone—ankylosing spondylitis	0.00132	0.00451	CcSEcCtD
Dextropropoxyphene—Bradycardia—Triamcinolone—ankylosing spondylitis	0.00128	0.00438	CcSEcCtD
Dextropropoxyphene—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.00128	0.00437	CcSEcCtD
Dextropropoxyphene—Visual disturbance—Methotrexate—ankylosing spondylitis	0.00127	0.00434	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Dexamethasone—ankylosing spondylitis	0.00125	0.00429	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Betamethasone—ankylosing spondylitis	0.00125	0.00429	CcSEcCtD
Dextropropoxyphene—Hallucination—Methylprednisolone—ankylosing spondylitis	0.00125	0.00428	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Betamethasone—ankylosing spondylitis	0.00124	0.00427	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Dexamethasone—ankylosing spondylitis	0.00124	0.00427	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Prednisolone—ankylosing spondylitis	0.00122	0.00418	CcSEcCtD
Dextropropoxyphene—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.00121	0.00414	CcSEcCtD
Dextropropoxyphene—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.00117	0.00402	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.00116	0.00399	CcSEcCtD
Dextropropoxyphene—Bradycardia—Dexamethasone—ankylosing spondylitis	0.00116	0.00398	CcSEcCtD
Dextropropoxyphene—Bradycardia—Betamethasone—ankylosing spondylitis	0.00116	0.00398	CcSEcCtD
Dextropropoxyphene—Hallucination—Betamethasone—ankylosing spondylitis	0.00113	0.00389	CcSEcCtD
Dextropropoxyphene—Hallucination—Dexamethasone—ankylosing spondylitis	0.00113	0.00389	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.00113	0.00388	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.00113	0.00387	CcSEcCtD
Dextropropoxyphene—Ataxia—Methotrexate—ankylosing spondylitis	0.00113	0.00387	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.00112	0.00385	CcSEcCtD
Dextropropoxyphene—Vision blurred—Prednisolone—ankylosing spondylitis	0.00112	0.00384	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.00112	0.00384	CcSEcCtD
Dextropropoxyphene—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.00111	0.0038	CcSEcCtD
Dextropropoxyphene—Visual impairment—Dexamethasone—ankylosing spondylitis	0.0011	0.00377	CcSEcCtD
Dextropropoxyphene—Visual impairment—Betamethasone—ankylosing spondylitis	0.0011	0.00377	CcSEcCtD
Dextropropoxyphene—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.00109	0.00374	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.00109	0.00374	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Prednisone—ankylosing spondylitis	0.00108	0.00372	CcSEcCtD
Dextropropoxyphene—Syncope—Prednisolone—ankylosing spondylitis	0.00107	0.00366	CcSEcCtD
Dextropropoxyphene—Eye disorder—Betamethasone—ankylosing spondylitis	0.00107	0.00365	CcSEcCtD
Dextropropoxyphene—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00107	0.00365	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00105	0.00358	CcSEcCtD
Dextropropoxyphene—Convulsion—Prednisolone—ankylosing spondylitis	0.00103	0.00353	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.00102	0.00349	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Betamethasone—ankylosing spondylitis	0.00102	0.00349	CcSEcCtD
Dextropropoxyphene—Bradycardia—Prednisone—ankylosing spondylitis	0.00101	0.00346	CcSEcCtD
Dextropropoxyphene—Discomfort—Prednisolone—ankylosing spondylitis	0.001	0.00343	CcSEcCtD
Dextropropoxyphene—Hallucination—Prednisone—ankylosing spondylitis	0.000988	0.00339	CcSEcCtD
Dextropropoxyphene—Syncope—Triamcinolone—ankylosing spondylitis	0.000981	0.00336	CcSEcCtD
Dextropropoxyphene—Syncope—Methylprednisolone—ankylosing spondylitis	0.000979	0.00335	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000961	0.00329	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000959	0.00329	CcSEcCtD
Dextropropoxyphene—Shock—Prednisolone—ankylosing spondylitis	0.000955	0.00327	CcSEcCtD
Dextropropoxyphene—Convulsion—Triamcinolone—ankylosing spondylitis	0.000948	0.00325	CcSEcCtD
Dextropropoxyphene—Tachycardia—Prednisolone—ankylosing spondylitis	0.000947	0.00325	CcSEcCtD
Dextropropoxyphene—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000946	0.00324	CcSEcCtD
Dextropropoxyphene—Eye disorder—Prednisone—ankylosing spondylitis	0.000928	0.00318	CcSEcCtD
Dextropropoxyphene—Drowsiness—Methotrexate—ankylosing spondylitis	0.000924	0.00317	CcSEcCtD
Dextropropoxyphene—Discomfort—Triamcinolone—ankylosing spondylitis	0.00092	0.00315	CcSEcCtD
Dextropropoxyphene—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000918	0.00315	CcSEcCtD
Dextropropoxyphene—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000898	0.00308	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Prednisone—ankylosing spondylitis	0.000897	0.00307	CcSEcCtD
Dextropropoxyphene—Syncope—Dexamethasone—ankylosing spondylitis	0.00089	0.00305	CcSEcCtD
Dextropropoxyphene—Syncope—Betamethasone—ankylosing spondylitis	0.00089	0.00305	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Prednisone—ankylosing spondylitis	0.000887	0.00304	CcSEcCtD
Dextropropoxyphene—Shock—Triamcinolone—ankylosing spondylitis	0.000878	0.00301	CcSEcCtD
Dextropropoxyphene—Insomnia—Prednisolone—ankylosing spondylitis	0.000878	0.00301	CcSEcCtD
Dextropropoxyphene—Shock—Methylprednisolone—ankylosing spondylitis	0.000876	0.003	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000874	0.003	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000873	0.00299	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000872	0.00299	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000872	0.00299	CcSEcCtD
Dextropropoxyphene—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000871	0.00299	CcSEcCtD
Dextropropoxyphene—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000869	0.00298	CcSEcCtD
Dextropropoxyphene—Malnutrition—Prednisone—ankylosing spondylitis	0.000864	0.00296	CcSEcCtD
Dextropropoxyphene—Convulsion—Dexamethasone—ankylosing spondylitis	0.00086	0.00295	CcSEcCtD
Dextropropoxyphene—Convulsion—Betamethasone—ankylosing spondylitis	0.00086	0.00295	CcSEcCtD
Dextropropoxyphene—Discomfort—Dexamethasone—ankylosing spondylitis	0.000835	0.00286	CcSEcCtD
Dextropropoxyphene—Discomfort—Betamethasone—ankylosing spondylitis	0.000835	0.00286	CcSEcCtD
Dextropropoxyphene—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000832	0.00285	CcSEcCtD
Dextropropoxyphene—Vision blurred—Prednisone—ankylosing spondylitis	0.000814	0.00279	CcSEcCtD
Dextropropoxyphene—Insomnia—Triamcinolone—ankylosing spondylitis	0.000807	0.00277	CcSEcCtD
Dextropropoxyphene—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000806	0.00276	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.0008	0.00274	CcSEcCtD
Dextropropoxyphene—Visual impairment—Methotrexate—ankylosing spondylitis	0.0008	0.00274	CcSEcCtD
Dextropropoxyphene—Shock—Dexamethasone—ankylosing spondylitis	0.000797	0.00273	CcSEcCtD
Dextropropoxyphene—Shock—Betamethasone—ankylosing spondylitis	0.000797	0.00273	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000796	0.00273	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000794	0.00272	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000794	0.00272	CcSEcCtD
Dextropropoxyphene—Agitation—Prednisone—ankylosing spondylitis	0.000794	0.00272	CcSEcCtD
Dextropropoxyphene—Tachycardia—Betamethasone—ankylosing spondylitis	0.00079	0.00271	CcSEcCtD
Dextropropoxyphene—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00079	0.00271	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000786	0.00269	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000784	0.00269	CcSEcCtD
Dextropropoxyphene—Eye disorder—Methotrexate—ankylosing spondylitis	0.000775	0.00266	CcSEcCtD
Dextropropoxyphene—Syncope—Prednisone—ankylosing spondylitis	0.000775	0.00266	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00077	0.00264	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00076	0.0026	CcSEcCtD
Dextropropoxyphene—Hypotension—Betamethasone—ankylosing spondylitis	0.000757	0.00259	CcSEcCtD
Dextropropoxyphene—Hypotension—Dexamethasone—ankylosing spondylitis	0.000757	0.00259	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000749	0.00257	CcSEcCtD
Dextropropoxyphene—Convulsion—Prednisone—ankylosing spondylitis	0.000749	0.00257	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000748	0.00256	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000736	0.00252	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000734	0.00252	CcSEcCtD
Dextropropoxyphene—Insomnia—Dexamethasone—ankylosing spondylitis	0.000733	0.00251	CcSEcCtD
Dextropropoxyphene—Insomnia—Betamethasone—ankylosing spondylitis	0.000733	0.00251	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000728	0.0025	CcSEcCtD
Dextropropoxyphene—Discomfort—Prednisone—ankylosing spondylitis	0.000727	0.00249	CcSEcCtD
Dextropropoxyphene—Malnutrition—Methotrexate—ankylosing spondylitis	0.000722	0.00248	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000715	0.00245	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000713	0.00244	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000713	0.00244	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000704	0.00241	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000699	0.0024	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000699	0.0024	CcSEcCtD
Dextropropoxyphene—Shock—Prednisone—ankylosing spondylitis	0.000694	0.00238	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000692	0.00237	CcSEcCtD
Dextropropoxyphene—Tachycardia—Prednisone—ankylosing spondylitis	0.000688	0.00236	CcSEcCtD
Dextropropoxyphene—Vision blurred—Methotrexate—ankylosing spondylitis	0.000681	0.00233	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000667	0.00229	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000667	0.00229	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000662	0.00227	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000662	0.00227	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000658	0.00225	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000656	0.00225	CcSEcCtD
Dextropropoxyphene—Dizziness—Prednisolone—ankylosing spondylitis	0.000642	0.0022	CcSEcCtD
Dextropropoxyphene—Asthenia—Triamcinolone—ankylosing spondylitis	0.00064	0.0022	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00064	0.00219	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00064	0.00219	CcSEcCtD
Dextropropoxyphene—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000639	0.00219	CcSEcCtD
Dextropropoxyphene—Insomnia—Prednisone—ankylosing spondylitis	0.000638	0.00219	CcSEcCtD
Dextropropoxyphene—Convulsion—Methotrexate—ankylosing spondylitis	0.000626	0.00214	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Prednisone—ankylosing spondylitis	0.000621	0.00213	CcSEcCtD
Dextropropoxyphene—Rash—Prednisolone—ankylosing spondylitis	0.000612	0.0021	CcSEcCtD
Dextropropoxyphene—Dermatitis—Prednisolone—ankylosing spondylitis	0.000611	0.0021	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000609	0.00209	CcSEcCtD
Dextropropoxyphene—Headache—Prednisolone—ankylosing spondylitis	0.000608	0.00208	CcSEcCtD
Dextropropoxyphene—Discomfort—Methotrexate—ankylosing spondylitis	0.000608	0.00208	CcSEcCtD
Dextropropoxyphene—Constipation—Prednisone—ankylosing spondylitis	0.000603	0.00207	CcSEcCtD
Dextropropoxyphene—Confusional state—Methotrexate—ankylosing spondylitis	0.000594	0.00204	CcSEcCtD
Dextropropoxyphene—Dizziness—Triamcinolone—ankylosing spondylitis	0.00059	0.00202	CcSEcCtD
Dextropropoxyphene—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000589	0.00202	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000581	0.00199	CcSEcCtD
Dextropropoxyphene—Asthenia—Dexamethasone—ankylosing spondylitis	0.000581	0.00199	CcSEcCtD
Dextropropoxyphene—Asthenia—Betamethasone—ankylosing spondylitis	0.000581	0.00199	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000578	0.00198	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000577	0.00198	CcSEcCtD
Dextropropoxyphene—Nausea—Prednisolone—ankylosing spondylitis	0.000577	0.00198	CcSEcCtD
Dextropropoxyphene—Vomiting—Triamcinolone—ankylosing spondylitis	0.000568	0.00195	CcSEcCtD
Dextropropoxyphene—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000566	0.00194	CcSEcCtD
Dextropropoxyphene—Rash—Triamcinolone—ankylosing spondylitis	0.000563	0.00193	CcSEcCtD
Dextropropoxyphene—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000562	0.00193	CcSEcCtD
Dextropropoxyphene—Rash—Methylprednisolone—ankylosing spondylitis	0.000562	0.00192	CcSEcCtD
Dextropropoxyphene—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000561	0.00192	CcSEcCtD
Dextropropoxyphene—Headache—Triamcinolone—ankylosing spondylitis	0.000559	0.00192	CcSEcCtD
Dextropropoxyphene—Headache—Methylprednisolone—ankylosing spondylitis	0.000558	0.00191	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Prednisone—ankylosing spondylitis	0.000558	0.00191	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000554	0.0019	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000554	0.0019	CcSEcCtD
Dextropropoxyphene—Hypotension—Methotrexate—ankylosing spondylitis	0.000551	0.00189	CcSEcCtD
Dextropropoxyphene—Dizziness—Dexamethasone—ankylosing spondylitis	0.000536	0.00184	CcSEcCtD
Dextropropoxyphene—Dizziness—Betamethasone—ankylosing spondylitis	0.000536	0.00184	CcSEcCtD
Dextropropoxyphene—Insomnia—Methotrexate—ankylosing spondylitis	0.000533	0.00183	CcSEcCtD
Dextropropoxyphene—Nausea—Triamcinolone—ankylosing spondylitis	0.00053	0.00182	CcSEcCtD
Dextropropoxyphene—Nausea—Methylprednisolone—ankylosing spondylitis	0.000529	0.00181	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000526	0.0018	CcSEcCtD
Dextropropoxyphene—Somnolence—Methotrexate—ankylosing spondylitis	0.000524	0.0018	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00052	0.00178	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000519	0.00178	CcSEcCtD
Dextropropoxyphene—Vomiting—Dexamethasone—ankylosing spondylitis	0.000515	0.00177	CcSEcCtD
Dextropropoxyphene—Vomiting—Betamethasone—ankylosing spondylitis	0.000515	0.00177	CcSEcCtD
Dextropropoxyphene—Rash—Dexamethasone—ankylosing spondylitis	0.000511	0.00175	CcSEcCtD
Dextropropoxyphene—Rash—Betamethasone—ankylosing spondylitis	0.000511	0.00175	CcSEcCtD
Dextropropoxyphene—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00051	0.00175	CcSEcCtD
Dextropropoxyphene—Dermatitis—Betamethasone—ankylosing spondylitis	0.00051	0.00175	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000509	0.00174	CcSEcCtD
Dextropropoxyphene—Headache—Dexamethasone—ankylosing spondylitis	0.000507	0.00174	CcSEcCtD
Dextropropoxyphene—Headache—Betamethasone—ankylosing spondylitis	0.000507	0.00174	CcSEcCtD
Dextropropoxyphene—Asthenia—Prednisone—ankylosing spondylitis	0.000506	0.00173	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000486	0.00166	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Prednisone—ankylosing spondylitis	0.000483	0.00165	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000482	0.00165	CcSEcCtD
Dextropropoxyphene—Nausea—Betamethasone—ankylosing spondylitis	0.000481	0.00165	CcSEcCtD
Dextropropoxyphene—Nausea—Dexamethasone—ankylosing spondylitis	0.000481	0.00165	CcSEcCtD
Dextropropoxyphene—Dizziness—Prednisone—ankylosing spondylitis	0.000466	0.0016	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000466	0.0016	CcSEcCtD
Dextropropoxyphene—Vomiting—Prednisone—ankylosing spondylitis	0.000448	0.00154	CcSEcCtD
Dextropropoxyphene—Rash—Prednisone—ankylosing spondylitis	0.000445	0.00152	CcSEcCtD
Dextropropoxyphene—Dermatitis—Prednisone—ankylosing spondylitis	0.000444	0.00152	CcSEcCtD
Dextropropoxyphene—Headache—Prednisone—ankylosing spondylitis	0.000442	0.00151	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000434	0.00149	CcSEcCtD
Dextropropoxyphene—Asthenia—Methotrexate—ankylosing spondylitis	0.000423	0.00145	CcSEcCtD
Dextropropoxyphene—Nausea—Prednisone—ankylosing spondylitis	0.000419	0.00144	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000403	0.00138	CcSEcCtD
Dextropropoxyphene—Dizziness—Methotrexate—ankylosing spondylitis	0.00039	0.00134	CcSEcCtD
Dextropropoxyphene—Vomiting—Methotrexate—ankylosing spondylitis	0.000375	0.00128	CcSEcCtD
Dextropropoxyphene—Rash—Methotrexate—ankylosing spondylitis	0.000372	0.00127	CcSEcCtD
Dextropropoxyphene—Dermatitis—Methotrexate—ankylosing spondylitis	0.000371	0.00127	CcSEcCtD
Dextropropoxyphene—Headache—Methotrexate—ankylosing spondylitis	0.000369	0.00127	CcSEcCtD
Dextropropoxyphene—Nausea—Methotrexate—ankylosing spondylitis	0.00035	0.0012	CcSEcCtD
